Inventor · disambiguated record
Joanne Kamens
Also filed as: KAMENS JOANNE S · KAMENS JOANNE SARA · KAMENS Joanne
30 granted patents·7 pending applications·956 citations·filing 1999–2021
98Inventor score
Files withPHIO PHARM CORP16RXI PHARMACEUTICALS CORP7KHVOROVA ANASTASIA6WOOLF TOD M2BASF AKTIENGESELLCHAFT1
Top patents by PatentIndex Score
37 records- 0199US8796443B2Reduced size self-delivering RNAi compoundsKHVOROVA ANASTASIA·Filed 2009·Granted Aug 5, 2014·105 cites·19 claims
- 0298US10633654B2Modified RNAi polynucleotides and uses thereofPHIO PHARM CORP·Filed 2018·Granted Apr 28, 2020·32 cites·20 claims
- 0398US10479992B2RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionalityPHIO PHARM CORP·Filed 2017·Granted Nov 19, 2019·27 cites·20 claims
- 0498US9938530B2RNA interference in skin indicationsRXI PHARMACEUTICALS CORP·Filed 2016·Granted Apr 10, 2018·25 cites·19 claims
- 0598US9303259B2RNA interference in skin indicationsRXI PHARMACEUTICALS CORP·Filed 2013·Granted Apr 5, 2016·46 cites·12 claims
- 0698US9175289B2Reduced size self-delivering RNAi compoundsRXI PHARMACEUTICALS CORP·Filed 2014·Granted Nov 3, 2015·80 cites·17 claims
- 0798US9080171B2Reduced size self-delivering RNAi compoundsKHVOROVA ANASTASIA·Filed 2011·Granted Jul 14, 2015·91 cites·15 claims
- 0898US8664189B2RNA interference in skin indicationsKHVOROVA ANASTASIA·Filed 2009·Granted Mar 4, 2014·60 cites·2 claims
- 0997US10913948B2RNA interference in dermal and fibrotic indicationsPHIO PHARM CORP·Filed 2018·Granted Feb 9, 2021·21 cites·7 claims
- 1097US10774330B2Reduced size self-delivering RNAI compoundsPHIO PHARM CORP·Filed 2015·Granted Sep 15, 2020·15 cites·19 claims
- 1197US10662430B2RNA interference in ocular indicationsPHIO PHARM CORP·Filed 2018·Granted May 26, 2020·14 cites·19 claims
- 1297US10167471B2Inhibition of PCSK9 through RNAIRXI PHARMACEUTICALS CORP·Filed 2016·Granted Jan 1, 2019·20 cites·11 claims
- 1397US9745574B2RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionalityWOOLF TOD M·Filed 2010·Granted Aug 29, 2017·44 cites·18 claims
- 1497US9340786B2RNA interference in dermal and fibrotic indicationsKHVOROVA ANASTASIA·Filed 2011·Granted May 17, 2016·49 cites·20 claims
- 1596US11667915B2RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionalityPHIO PHARM CORP·Filed 2019·Granted Jun 6, 2023·10 cites·20 claims
- 1696US10240149B2Reduced size self-delivering RNAi compoundsPHIO PHARM CORP·Filed 2015·Granted Mar 26, 2019·23 cites·21 claims
- 1796US10184124B2RNA interference in ocular indicationsRXI PHARMACEUTICALS CORP·Filed 2015·Granted Jan 22, 2019·23 cites·14 claims
- 1896US10041073B2Reduced size self-delivering RNAi compoundsKHVOROVA ANASTASIA·Filed 2011·Granted Aug 7, 2018·24 cites·24 claims
- 1996US9963702B2RNA interference in dermal and fibrotic indicationsRXI PHARMACEUTICALS CORP·Filed 2016·Granted May 8, 2018·23 cites·20 claims
- 2096US9074211B2Inhibition of MAP4K4 through RNAIWOOLF TOD M·Filed 2009·Granted Jul 7, 2015·50 cites·11 claims
- 2195US10138485B2Neutral nanotransportersKHVOROVA ANASTASIA·Filed 2009·Granted Nov 27, 2018·22 cites·15 claims
- 2295US9493774B2Inhibition of PCSK9 through RNAiKAMENS Joanne·Filed 2010·Granted Nov 15, 2016·45 cites·10 claims
- 2395US9095504B2RNA interference in ocular indicationsLIBERTINE LYN·Filed 2011·Granted Aug 4, 2015·50 cites·10 claims
- 2494US11118178B2Reduced size self-delivering RNAI compoundsPHIO PHARM CORP·Filed 2019·Granted Sep 14, 2021·8 cites·10 claims
- 2594US10876119B2Reduced size self-delivering RNAI compoundsPHIO PHARM CORP·Filed 2018·Granted Dec 29, 2020·7 cites·20 claims
- 2694US10815485B2RNA interference in skin indicationsPHIO PHARM CORP·Filed 2018·Granted Oct 27, 2020·8 cites·5 claims
- 2793US11584933B2RNA interference in ocular indicationsPHIO PHARM CORP·Filed 2020·Granted Feb 21, 2023·2 cites·20 claims
- 2890US11396654B2Neutral nanotransportersPHIO PHARM CORP·Filed 2018·Granted Jul 26, 2022·4 cites·19 claims
- 2990US10131904B2Modified RNAi polynucleotides and uses thereofPAVCO PAMELA A·Filed 2009·Granted Nov 20, 2018·23 cites·8 claims
- 3086US11254940B2Inhibition of MAP4K4 through RNAiPHIO PHARM CORP·Filed 2015·Granted Feb 22, 2022·5 cites·9 claims
- 3177US2021147849A1Reduced size self-delivering rnai compoundsPHIO PHARM CORP·Filed 2020·Application pending·0 cites
- 3272US2021261968A1Rna interference in dermal and fibrotic indicationsPHIO PHARM CORP·Filed 2021·Application pending·0 cites
- 3365US2019218557A1Inhibition of pcsk9 through rnaiPHIO PHARM CORP·Filed 2018·Application pending·0 cites
- 3455US2011251258A1Rnai constructs and uses thereofRXI PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 3549US2008227704A1CXCL13 binding proteinsKAMENS JOANNE S·Filed 2007·Application pending·0 cites
- 3644US2003219427A1TPL-2/COT kinase and methods of useFiled 2003·Application pending·0 cites
- 3728US2002099169A1Tpl-2/cot kinase and methods of useBASF AKTIENGESELLCHAFT·Filed 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joanne Kamens files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →